Advertisement

What to know about medical cannabis

Are proponents or detractors just blowing smoke?

cannibis

Updated on February 14, 2025.

Depending on whom you talk to, medical cannabis (also known as medical marijuana) may be an effective remedy for everything from cancer to chronic pain, or a dangerous and illegal drug with no place in medicine. 

Some evidence, however, suggests that legal cannabis could replace alternative treatments and save the government money on healthcare bills. What's more, data suggest that cannabis has a real effect on people’s health.

But can it really help treat medical conditions? Here’s what to know. 

Cannabis’ complex legal status 

Cannabis’ legal status is complicated, and that affects how it’s studied. Almost every state allows for its medical use. About half of states allow for its regulated recreational use.

But federally, cannabis is classified as a Schedule I drug under the Controlled Substances Act, along with substances like heroin and ecstasy. That means the federal government has found it to have a high potential for abuse with no medical use, and to be unsafe. 

Products that contain either of cannabis’ two main ingedients can’t be sold legally as dietary supplements, either. Those two ingredients are:

  • Delta-9-tetrahydrocannabinol (THC)
  • Cannabidiol (CBD)

The status of cannabis as a Schedule I drug makes getting funding for research into its medical benefits difficult, says Keith Roach, MD, Associate Professor in Clinical Medicine in the division of general medicine at Weill Cornell Medical College and New York Presbyterian Hospital.

“I think it should be reclassified because there’s potential for marijuana to be used in other conditions,” says Dr. Roach. “Saying it has no medical validity is a mistake. Let’s study it.”

Roach says the future of medical marijuana research “depends entirely on the federal government and what they choose to do. Right now, it’s very difficult for researchers to do any kind of good research.”

Elements of cannabis

In addition, cannabis isn’t just one thing—as with any plant, it contains hundreds of compounds with potential health effects, including some very important ones called cannabinoids. The two most common cannabinoids are THC, which is responsible for the “high” that cannabis causes, and CBD, which does not have psychoactive properties.

In November 2017, the World Health Organization (WHO) published a report stating that CBD in its pure form is safe, with little potential for substance abuse and no evidence of harm to public health. The U.S. Drug Enforcement Administration classifies prescription CBD (Epidiolex) as a Schedule V controlled substance, a category that also includes cough syrups. CBD extracted from hemp is not controlled.

CBD is not risk-free—it can interact with other drugs and may cause vomiting, diarrhea, sleepiness, or liver abnormalities. But it also has potential health benefits (read on to learn more). And THC has important medical uses as well.

In fact, the effectiveness of certain compounds found in cannabis is no longer in question, says Roach. “But it’s still controversial because marijuana itself has a lot of different substances in it. We try to isolate one substance and say ‘This is what’s important,’ when it may be several things acting in concert. It’s very difficult to study.”

The health problems marijuana can (and can’t) treat 

Cannabis and its many compounds are still being studied and probably will be for many years, so there is a lot that researchers still don’t know. Currently, though, evidence supports the use of cannabis or cannabinoids to treat the following conditions:

  • Certain types of pain
  • Seizure disorders
  • Stimulating the appetite in some patients
  • Spastic muscles in people with multiple sclerosis
  • Nausea and vomiting due to chemotherapy
  • Parkinson’s disease

Two cannabis-derived products called dronabinol and nabilone have FDA-approved indications to treat certain conditions, including chemotherapy-induced nausea and vomiting. And there is an FDA-approved prescription formulation of cannabidiol to treat certain types of seizures in children.

The science is less clear so far on whether it helps with the following:

  • Neurodegenerative diseases
  • Anxiety and post-traumatic stress disorder (PTSD)
  • Addiction
  • Cancer
  • Inflammation

With regard to cancer, there are some promising lines of research, but many of the studies are in mice. It’s still too soon to be sure of how best to use cannabinoids to help cancer patients. Just as cannabis contains many different compounds, “cancer” includes many different cancer types. So it will be important for researchers to sort out which compounds work, which don’t, and which might even cause harm, in specific types of cancer patients.

In at least one type of cancer, for instance, there is preliminary evidence that cannabinoids could accelerate the disease. Other studies suggest cannabis can interfere with chemotherapy and make people more vulnerable to viral infections. In fact, some scientists have pointed out that cannabis’ ability to suppress the immune system—and the potential dangers to immunocompromised people—is too often overlooked.

Another worrisome possibility is that people could develop cannabis use disorder (CUD), when people use it in a problematic way. Adolescents are much more prone than adults to developing CUD. About 1 in 10 people who start smoking cannabis become addicted. A 2022 study published in JAMA Network Open found evidence that immediate use of medical cannabis by people with pain, insomnia, and symptoms of anxiety or depression increased the risk of CUD without helping them with most of their symptoms.

Responsible use 

If you use cannabis or cannabinoids, be aware of its other risks, which may include:

  • Interactions with other medications, especially those that affect your mood or make you drowsy
  • Interactions with alcohol, tobacco, or illicit drugs
  • Higher chance of bleeding if you’re on blood thinners
  • Effects on heart rate or blood pressure
  • Heart attack
  • Testicular cancer
  • Effects on your memory, judgment, and decision-making
  • Psychosis
  • Severe nausea and vomiting (cannabinoid hyperemesis syndrome, or CHS)
  • Lower birth weight if smoked during pregnancy
  • Fainting or falls upon standing up
  • Accidental poisonings, especially of children
  • Street cannabis laced with PCP or other drugs

Be aware, too, that due to spotty regulations and quality control, many seemingly innocent preparations of CBD oil are mislabeled or contaminated. In one 2020 study by the U.S. Food and Drug Administration, for example, scientists tested 147 CBD or hemp products being sold on the internet. Of 102 whose labels stated they had a certain amount of CBD, 18 had less than 80 percent of the advertised amount, while 37 had more than 120 percent of the advertised amount. The kicker: About half the samples also contained THC, which means that people using what they think are CBD products could inadvertently be intoxicated by THC.

The Department of Transportation has warned that using a CBD product will not be accepted as an explanation for a positive drug test. One truck driver reportedly lost his job this way.

Heavy metals have shown up in these products, leading in one case to a July 2020 nationwide recall due to lead contamination. Pesticides, microbes, and carcinogens have also been detected in some products.

Cannabis impairs driving, according to the National Institute on Drug Abuse, so if you’re using it it’s best not to get behind the wheel. It is also particularly detrimental to teenagers’ developing brains, impairing thinking and memory for days after use. 

Cannabis in some forms has a place in medicine—probably many places. But there is still a lot we don’t know, and fraudulent products are common. If you think medical cannabis might be right for you, protect yourself by consulting a qualified healthcare provider you trust.

Article sources open article sources

Centers for Disease Control and Prevention. State Medical Cannabis Laws. February 16, 2024.
Drug Enforcement Administration. Drug Scheduling. July 2018.
National Center for Complementary and Integrative Health. Cannabis (Marijuana) and Cannabinoids: What You Need To Know. Last Updated November 2019.
 Legare CA, Raup-Konsavage WM, Vrana KE. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. Pharmacology. 2022;107(3-4):131-149.
World Health Organization. Drugs (psychoactive): Cannabidiol (compound of cannabis).  December 19, 2017.
Drug Enforcement Administration, Department of Justice. Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements. Final order. Fed Regist. 2018;83(189):48950-48953.
Federal Register. Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements. A Rule by the Drug Enforcement Administration on 09/28/2018.


Bradford AC, Bradford WD. Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D. Health Aff (Millwood). 2016;35(7):1230-1236.
Bradford AC, Bradford WD. Medical Marijuana Laws May Be Associated With A Decline In The Number Of Prescriptions For Medicaid Enrollees. Health Aff (Millwood). 2017;36(5):945-951.
California Attorney General. Update on Legal Status of Products Containing Cannabidiol (CBD), In Light of Federal 2014 and 2018 Farm Bills.
Madeo G, Kapoor A, Giorgetti R, Busardò FP, Carlier J. Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review. Curr Neuropharmacol. 2023;21(11):2323-2342.
Zhou Z, Paine MF, Spindle TR, Huang SM, Zhang L. Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges. Clin Pharmacol Ther. 2022 Apr;111(4):732-735.
Khoury M, Cohen I, Bar-Sela G. "The Two Sides of the Same Coin"-Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained. Pharmaceutics. 2022;14(2):389. Published 2022 Feb 10.
United States Food & Drug Administration. FDA and Cannabis: Research and Drug Approval Process. October 1, 2020.
Badowski ME. A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics. Cancer Chemother Pharmacol. 2017;80(3):441-449.
Silczuk A, Smułek D, Kołodziej M, Gujska J. The Construct of Medical and Non-Medical Marijuana-Critical Review. Int J Environ Res Public Health. 2022;19(5):2769. Published 2022 Feb 27.
Seltzer ES, Watters AK, MacKenzie D Jr, Granat LM, Zhang D. Cannabidiol (CBD) as a Promising Anti-Cancer Drug. Cancers (Basel). 2020;12(11):3203. Published 2020 Oct 30.
O'Brien K. Cannabidiol (CBD) in Cancer Management. Cancers (Basel). 2022;14(4):885. Published 2022 Feb 10.
American Cancer Society. Marijuana and Cancer. Last Revised August 4, 2020.
Bodine, M. Kemp AK. Medical Cannabis Use in Oncology. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
Martínez-Martínez E, Martín-Ruiz A, Martín P, Calvo V, Provencio M, García JM. CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway. Oncotarget. 2016;7(42):68781-68791.
Ghasemiesfe M, Barrow B, Leonard S, Keyhani S, Korenstein D. Association Between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open. 2019 Nov 1;2(11):e1916318.
Patel J, Marwaha R. Cannabis Use Disorder. [Updated 2022 Feb 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
Yale Medicine. Cannabis/Marijuana Use Disorder. Accessed February 14, 2025.
Gilman JM, Schuster RM, Potter KW, et al. Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(3):e222106.
Kaiser Permanente. Medical Marijuana. November 8, 2021.
Mayo Clinic. Medical marijuana. December 4, 2021.
Report to the U.S. House “Sampling Study of the Current Cannabidiol Marketplace to Determine the Extent That Products are Mislabeled or Adulterated Report in Response to Further Consolidated Appropriations Act, 2020,” FDA. July 2020.
United States Food & Drug Administration. Summitt Labs Issues Voluntary Nationwide Recall of KORE ORGANIC Watermelon CBD Oil Due to High Lead Results. July 28, 2020.
Evans DG. Medical Fraud, Mislabeling, Contamination: All Common in CBD Products. Mo Med. 2020;117(5):394-399.
Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of Cannabis Use With Cardiovascular Outcomes Among US Adults. J Am Heart Assoc. 2024 Mar 5;13(5):e030178. 
National Institute on Drug Abuse. Cannabis (Marijuana) Research Report. What are marijuana’s effects on other aspects of physical health?  July 2020.
Song A, Myung NK, Bogumil D, Ihenacho U, Burg ML, Cortessis VK. Incident testicular cancer in relation to using marijuana and smoking tobacco: A systematic review and meta-analysis of epidemiologic studies. Urol Oncol. 2020 Jul;38(7):642.e1-642.e9. 
National Institute on Drug Abuse. Cannabis (Marijuana) Research Report. Is there a link between marijuana use and psychiatric disorders? July 2020.
Centers for Disease Control and Prevention. Cannabis and Public Health. Cannabis and Poisoning. February 15, 2024.
Hazekamp A. The Trouble with CBD Oil. Med Cannabis Cannabinoids. 2018;1(1):65-72. Published 2018 Jun 12.
Wiley J, Gourdet CK, Thomas BF. Cannabidiol: Science, Marketing, and Legal Perspectives. Research Triangle Park (NC): RTI Press; 2020 Apr.
United States Department of Transportation. DOT "CBD" Notice. February 18, 2020.
Montoya Z, Conroy M, Vanden Heuvel BD, Pauli CS, Park SH. Cannabis Contaminants Limit Pharmacological Use of Cannabidiol. Front Pharmacol. 2020;11:571832. Published 2020 Sep 11.
National Institute on Drug Abuse. Cannabis (Marijuana) Research Report. Does marijuana use affect driving? July 2020.
Evans DG. Medical Fraud, Mislabeling, Contamination: All Common in CBD Products. Mo Med. 2020 Sep-Oct;117(5):394-399.
Gilman JM, Schuster RM, Potter KW, et al. Effect of Medical Marijuana Card Ownership on Pain, Insomnia, and Affective Disorder Symptoms in Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(3):e222106.
Voelker R. FDA Says It Supports Cannabis Drug Development via Regulatory Pathways. JAMA. 2020;323(7):600.

More On

How does tardive dyskinesia affect my mental health?

video

How does tardive dyskinesia affect my mental health?
Tardive dyskinesia can be a side effect of some medications used to treat mental illness. Learn more about this condition.
How much is too much ibuprofen?

article

How much is too much ibuprofen?
A study found 15 percent of Americans taking the drug went over the maximum weekly dosage.
Surprising reasons to take aspirin—and when to skip it

slideshow

Surprising reasons to take aspirin—and when to skip it
From boosting your beauty regimen to helping you live longer, aspirin's a versatile little pill. But it's important to know its potential side effects...
What are some risks of anti-anxiety medications?

video

What are some risks of anti-anxiety medications?
Anti-anxiety medications can be very effective if closely monitored by a doctor for short doses; but if abused or taken too long, there can be long-te...
What are the symptoms of tardive dyskinesia?

video

What are the symptoms of tardive dyskinesia?
Tardive Dyskinesia (TD) is a neurological disorder that causes involuntary movements and the symptoms can vary from person to person. This video shows...